Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment

SIMPLE SUMMARY: Because FOLFIRINOX shows high prevalence of hematologic toxicity, it is meaningful to investigate of usefulness of primary G-CSF prophylaxis in metastatic pancreatic cancer patients. In this retrospective study, a total of 165 patients were divided into G-CSF user group (n = 57) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jae Hyup, Shin, Dong Woo, Kim, Jaihwan, Lee, Jong-Chan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692712/
https://www.ncbi.nlm.nih.gov/pubmed/33120908
http://dx.doi.org/10.3390/cancers12113137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692712/
https://www.ncbi.nlm.nih.gov/pubmed/33120908
http://dx.doi.org/10.3390/cancers12113137

Ejemplares similares